Steris | STE - Operating Profit

Stock Price
263.97
Daily Change
1.37 0.52%
Monthly
2.81%
Yearly
20.90%
Q1 Forecast
254.51

Steris reported $270.9M in Operating Profit for its fiscal quarter ending in September of 2025.





Operating Profit Change Date
3M USD 1.21B 394M Dec/2025
Avanos Medical USD 18.97M 72.63M Sep/2025
Baxter International USD 201.2M 70.8M Sep/2025
Becton, Dickinson and Co. USD 826M 153M Sep/2025
Boston Scientific USD 1.04B 98M Sep/2025
CONMED USD 36.62M 24.74M Dec/2025
Cooper Companies USD 140.4M 35.3M Sep/2025
Dexcom USD 242.5M 29.9M Sep/2025
Ecolab USD 786.4M 49.2M Sep/2025
Edwards Lifesciences USD 425.1M 5.8M Sep/2025
Fortive USD 159.6M 62.6M Sep/2025
Getinge SEK 1.08B 900M Dec/2024
Globus Medical USD -117.52M 8.43M Sep/2025
Haemonetics USD 58.49M 12.35M Sep/2025
Hologic USD 237M 16M Dec/2025
Idexx Laboratories USD 354.85M 18.2M Sep/2025
Insulet USD 117.7M 3.4M Sep/2025
Integra LifeSciences USD 11.76M 13.07M Sep/2025
Intuitive Surgical USD 865.3M 97.5M Dec/2025
J&J USD 5.59B 1.81B Dec/2025
Masimo USD 83.6M 19.1M Sep/2025
Olympus JPY 33.57B 17.21B Sep/2025
Owens Minor USD 56.75M 56.63M Jun/2025
ResMed USD 497.6M 35.25M Dec/2025
Steris USD 270.9M 45.6M Sep/2025
Stryker USD 1.97B 609M Dec/2025
Tandem Diabetes Care USD -22.86M 9M Sep/2025
Teleflex USD -408.9M 586.38M Sep/2025
Thermo Fisher Scientific USD 2.3B 226M Dec/2025
Zimmer Biomet Holdings USD 338.3M 58.1M Sep/2025